Related Experiment Video
Updated: May 26, 2026
05:19
A New Technique for Treating Low-risk Prostate Cancer—Super Active Surveillance
Published on: November 7, 2025
Staging of prostate cancer
Liang Cheng1, Rodolfo Montironi, David G Bostwick
1Department of Pathology and Laboratory Medicine, Indiana University School of Medicine, Indianapolis, IN 46202, USA. liang_cheng@yahoo.com
Histopathology
|January 4, 2012
Summary
Accurate prostate cancer staging is crucial for treatment. Current TNM staging has limitations, particularly for T2 classification and lymph node assessment. Future systems may improve individualized care by refining these categories.
Area of Science:
- Oncology
- Urology
Background:
- Prostate carcinoma (PCa) significantly impacts global cancer morbidity and mortality.
- Accurate staging is essential for prognosis and treatment planning in PCa.
- Existing staging systems face challenges in reflecting the complex clinical course of prostate cancer.
Purpose of the Study:
- To review recent advancements and controversies in prostate cancer staging.
- To evaluate the current American Joint Committee on Cancer/Union Internationale Contre le Cancer (AJCC/UICC) TNM staging system.
- To propose improvements for future staging classifications.
Main Methods:
- Review of recent progress and controversial issues in prostate cancer staging.
- Analysis of the 2010 AJCC/UICC TNM staging system, focusing on T2 subclassification and lymph node status.
- Examination of data linking tumor volume to clinical outcomes.
Main Results:
- The current TNM system is widely used but has uncertainties, especially in T2 subclassification.
- The three-tiered T2 classification for organ-confined PCa may be superfluous.
- Lymph node status is a key prognostic factor, with tumor volume in nodes correlating with aggressiveness.
Conclusions:
- Future TNM staging should consider a tumor size-based substaging for pT2 cancer.
- Subclassification of node-positive cancer based on nodal tumor volume (e.g., largest metastasis diameter, number of positive nodes) is recommended.
- Refined staging systems can enhance individualized care for prostate cancer patients.
